The US Food and Drug Administration's denial of Public Citizen's request for a temporary halt to the approval of new opioids was not surprising given the agency's recent regulatory actions. But the petition drew attention to the agency's regulation of opioids and reflects the consumer advocacy group's mixed record in pushing for enforcement action on prescription drugs.
While Public Citizen routinely submits citizen petitions asking the FDA to remove specific drug products from the market or add...